Nikolaus R. McFarland, Ph.D.
Affiliations: | 1988-1992 | University of Chicago, Chicago, IL | |
| 1992-2002 | University of Rochester, Rochester, NY | ||
| 2002-2006 | Neurology | University of Virginia School of Medicine, Charlottesville, VA, United States | |
| 2006-2010 | Neurology | Massachusetts General Hospital & Harvard Medical School, Boston, MA, United States | |
| 2010- | Neurology | University of Florida College of Medicine |
Area:
Parkinsonism, atypical parkinson disorders, neurodegenerative models, AAVWebsite:
https://movementdisorders.ufhealth.org/team/faculty-fellows/nikolaus-mcfarland-m-d-ph-d/Google:
"Nikolaus McFarland"Mean distance: 15.59 (cluster 17) | S | N | B | C | P |
Parents
Sign in to add mentor| Donna L. Hammond | research assistant | 1990-1992 | Chicago | |
| Suzanne Haber | grad student | 2001 | Rochester | |
| (Anatomic evidence indicating a dual role for specific thalamic relay nuclei in basal ganglia circuitry.) | ||||
| G Frederick Wooten | grad student | 2002-2006 | UVA School of Medicine | |
| (Residency) | ||||
| John Herbert Growdon | post-doc | 2006-2008 | Massachusetts General Hospital, Harvard Medical School | |
| Bradley T. Hyman | post-doc | 2006-2010 | Massachusetts General Hospital & Harvard Medical School | |
| Pamela J. McLean | post-doc | 2006-2010 | Mayo Clinic Florida | |
| Michael A. Schwarzschild | post-doc | 2008-2010 | Massachusetts General Hospital and Harvard Medical School | |
| Todd Golde | research scientist | 2010- | University of Florida College of Medicine | |
| Michael S. Okun | research scientist | 2010- | University of Rochester, School of Medicine and Dentistry | |
Children
Sign in to add trainee| Angela Hardwick | grad student | University of Florida College of Medicine | |
| Umer Akbar | post-doc | University of Florida College of Medicine | |
| Mayur S. Parmar | post-doc | 2015-2019 | University of Florida School of Medicine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Guarín DL, Wong JK, McFarland NR, et al. (2024) What the trained eye cannot see: Quantitative kinematics and machine learning detect movement deficits in early-stage Parkinson's disease from videos. Parkinsonism & Related Disorders. 127: 107104 |
| Guarin DL, Wong JK, McFarland NR, et al. (2024) Characterizing Disease Progression in Parkinson's Disease from Videos of the Finger Tapping Test. Ieee Transactions On Neural Systems and Rehabilitation Engineering : a Publication of the Ieee Engineering in Medicine and Biology Society. 32: 2293-2301 |
| Mir MJ, Herndon NE, Wagle Shukla A, et al. (2024) The Vocal Flutter of Multiple System Atrophy: A Parkinsonian-Type Phenomenon? Movement Disorders Clinical Practice |
| Wilkes BJ, Tobin ER, Arpin DJ, et al. (2023) Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. Npj Parkinson's Disease. 9: 85 |
| Patterson CG, Joslin E, Gil AB, et al. (2022) Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial. Trials. 23: 855 |
| Mitchell T, Wilkes BJ, Archer DB, et al. (2022) Advanced diffusion imaging to track progression in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neuroimage. Clinical. 34: 103022 |
| Quattrone A, Bianco MG, Antonini A, et al. (2022) Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Arpin DJ, Mitchell T, Archer DB, et al. (2021) Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society |
| Hass EW, Sorrentino ZA, Lloyd GM, et al. (2021) Robust α-synuclein pathology in select brainstem neuronal populations is a potential instigator of multiple system atrophy. Acta Neuropathologica Communications. 9: 80 |
| Tanner CM, Cummings SR, Schwarzschild MA, et al. (2021) The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism. Npj Parkinson's Disease. 7: 16 |